Criteria Caixa’s Boston Scientific BSX Stock Holding History

Criteria Caixa’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-32,000	Closed	-$1.19M	–	50
2022 Q2	$1.19M	Buy	+32,000	New	+$1.3M	0.16%	36
2022 Q1	–	Sell	-48	Closed	-$2.04M	–	44
2021 Q4	$2.04M	Sell	48 -30,952	-100%	-$1.3M	0.25%	28
2021 Q3	$1.35M	Buy	31,000 +17,000	+121%	+$752K	0.19%	34
2021 Q2	$599K	Hold	14,000	–	–	0.09%	38
2021 Q1	$541K	Buy	+14,000	New	+$530K	0.09%	32

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Criteria Caixa's BSX Position: Q3 2024 in Review

Criteria Caixa sold out of Boston Scientific (BSX) in Q3 2024, closing a stake of 127,684 shares — an estimated $9.83M sold.

Criteria Caixa first reported a position in BSX in Q4 2020 and held it in 15 quarters. The position peaked at $31.1M in Q1 2023. 1,399 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

Criteria Caixa reported no remaining Boston Scientific position as of Q3 2024 after selling out during the quarter.
Criteria Caixa sold 127,684 Boston Scientific shares in Q3 2024, an estimated $9.83M.
Criteria Caixa first reported a position in Boston Scientific in Q4 2020 and held it in 15 quarters.
Criteria Caixa's Boston Scientific position peaked at $31.1M in Q1 2023.
1,399 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Criteria Caixa's 13F filing for Q3 2024, filed 18 Mar 2025.